| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $20,209,618 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31HL178200 | Myocarditis is necessary for the development of arrhythmogenic cardiomyopathy | 000 | 2 | NIH | 2/6/2026 | $37,609 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 001 | 1 | NIH | 2/4/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30HD118749 | Image-Based Modeling of Pediatric Charcot-Marie-Tooth Disease Relative to Neuromuscular Development and Treatment | 000 | 1 | NIH | 2/4/2026 | $54,538 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F31AG094290 | Age-Dependent CD7 Functions in T Cell Responses | 000 | 1 | NIH | 2/6/2026 | $40,783 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA278348 | Metabolic Obesity Phenotypes and Obesity-related Cancer Survival | 000 | 3 | NIH | 12/16/2025 | $54,538 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 2/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 2/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 04 | 3 | HRSA | 2/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 12/9/2025 | $100,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 12/9/2025 | $50,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T9952113 | Value-Based Medical Student Education Training Program | 03 | 3 | HRSA | 12/9/2025 | $1,025,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | H7600470 | Ryan White Part C Outpatient EIS Program | 00 | 30 | HRSA | 12/29/2025 | $292,696 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012286 | Calypso: a web software system supporting team-based, longitudinal genomic diagnostic care | 000 | 5 | NIH | 1/2/2026 | $887,934 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HG012252 | New algorithms and tools for large-scale genomic analyses | 000 | 5 | NIH | 1/21/2026 | $658,073 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HD099487 | Comorbid Disease in Women with Primary Ovarian Insufficiency | 000 | 7 | NIH | 1/16/2026 | $502,577 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK128592 | Structures and Pharmacology of Cation-Chloride Cotransporters | 000 | 5 | NIH | 2/9/2026 | $680,627 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK126903 | Validation and Identification of Genetic Variants in Peyronie's and Dupuytren's Disease that Predispose to Fibrosis and Inflammation | 000 | 5 | NIH | 12/17/2025 | $547,271 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035669 | Understanding and optimizing the influence of glaucoma drainage implant surface architecture and design to prevent post-operative fibrosis | 000 | 3 | NIH | 1/28/2026 | $358,559 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01EY035158 | Regulation of Retinal Neurogenesis by Foxp1 | 000 | 3 | NIH | 12/4/2025 | $568,043 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032810 | A multicity study of wintertime inversions and acute cardiorespiratory health events in the western U.S. | 000 | 5 | NIH | 2/11/2026 | $453,256 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES024681 | BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS | 000 | 15 | NIH | 1/13/2026 | $499,822 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA212415 | Transcriptional Regulation of Lung Cancer Identity | 000 | 9 | NIH | 12/18/2025 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA131261 | Studying the initiation, progression and therapy of lung cancer in mouse models | 000 | 14 | NIH | 1/16/2026 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA264971 | Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s | 000 | 5 | NIH | 1/28/2026 | $468,901 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA259686 | A tissue viability imaging biomarker for use in non-invasive breast cancer therapy | 000 | 5 | NIH | 1/12/2026 | $540,619 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA267990 | Access, Utilization and Outcomes of Cancer Services in the Era of Telemedicine | 000 | 5 | NIH | 2/12/2026 | $323,658 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG080440 | Area-level Socio-economic Conditions and Individual-level Health and Mortality: Exploring Place-Based Mechanisms and Individual-level Psychosocial Processes | 000 | 4 | NIH | 1/12/2026 | $475,283 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG074535 | LOOH-induced muscle atrophy with age | 000 | 5 | NIH | 12/12/2025 | $478,750 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG077751 | Integrative Mechanisms of Vascular Aging | 000 | 4 | NIH | 1/12/2026 | $413,711 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG076748 | Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation | 000 | 4 | NIH | 1/13/2026 | $401,253 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162943 | Microbial Ecology-Guided Discovery of Antibacterial Drugs | 000 | 5 | NIH | 1/8/2026 | $635,442 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI173406 | Early life regulation of microbiota specific thymic T cell development | 000 | 4 | NIH | 12/5/2025 | $817,057 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG097508 | Development of a Plasma Biomarker for TDP-43 Proteinopathy | 000 | 1 | NIH | 12/23/2025 | $437,252 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG061376 | Endolysosomal Regulation of Amino Acid Homeostasis in Aging | 000 | 8 | NIH | 1/21/2026 | $403,709 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AA030881 | Transcriptional Regulation of Alcohol Sensitivity and Tolerance | 000 | 4 | NIH | 1/30/2026 | $525,035 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00GM146031 | Molecular mechanisms of ZAK- and GCN2-mediated signaling in response to ribotoxic stress | 000 | 3 | NIH | 1/26/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00DA059957 | Cross-region neural mechanisms that support conditioned taste aversion | 000 | 3 | NIH | 1/21/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00GM155552 | The regulatory landscape of segmentally duplicated genes: Implications for human evolution and disease | 000 | 3 | NIH | 1/9/2026 | $248,965 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00EY032119 | Bridging gap in comparative biology using the tree shrew visual system | 000 | 6 | NIH | 12/22/2025 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DA062174 | Evaluating an Interdisciplinary Intervention to Improve Transitions to Primary Care for Hospitalized Patients with Substance Use Disorders | 000 | 2 | NIH | 2/6/2026 | $210,600 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K22CA276255 | Enhancing motivation to quit smoking via self-help intervention targeted to cancer type: A pilot RCT | 000 | 3 | NIH | 1/26/2026 | $174,839 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 000 | 4 | NIH | 1/29/2026 | $486,266 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM153175 | Out of the shadows: Illuminating mammalian histidine phosphorylation | 000 | 3 | NIH | 1/16/2026 | $346,500 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 000 | 3 | NIH | 12/17/2025 | $366,923 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA247994 | Mitochondrial lateral transfer during metastasis | 000 | 6 | NIH | 2/2/2026 | $317,048 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37NS102978 | Noncanonical glutamate signaling in the origins of the migraine attack | 000 | 8 | NIH | 2/11/2026 | $590,904 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA246183 | Circulating Cell-Free DNA as a Personalized Biomarker to Diagnose and Monitor Glioblastoma Extension | 000 | 7 | NIH | 2/2/2026 | $316,637 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA276044 | Liquid Biopsy in Myeloma to Inform Outcome and Treatment Decisions | 000 | 4 | NIH | 12/18/2025 | $317,049 |
| | 2026 | 2026 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS137105 | Defining the contribution from endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice | 000 | 2 | NIH | 12/12/2025 | $231,000 |
|
